Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Security

Emmaus Life Sciences, Inc Common Stock · EMMA

EMMAOTCCommon stockCurrentCIK 822370Updated Nov 16, 2026

Company: Emmaus Life Sciences, Inc. →

Name history
MYnd Analytics, Inc. · through Jul 12, 2019CNS RESPONSE, INC. · through Dec 10, 2015STRATIVATION, INC. · through Mar 1, 2007SalesTactix, Inc. · through Aug 23, 2005AGE RESEARCH INC · through Aug 5, 2004

EMMA price & chart

Provider market data

Loading TradingView…

OTC:EMMA on TradingView ↗

TradingView · Data may be delayed

About the company

Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease. Endari® (L-glutamine oral powder), indicated to reduce the acute complications of sickle cell disease in adults and children 5 years and older, is approved for marketing in the United States, Israel, Kuwait, Qatar, the United Arab Emirates, Bahrain and Oman and is available on a named patient or early access basis in France, the Netherlands, and the Kingdom of Saudi Arabia, where Emmaus’ application for marketing authorization is awaiting final action by the Saudi Food & Drug Authority. For more information, please visit www.emmausmedical.com.

8-K · 2026-08-14 · 0001213900-26-089912

Company description from the cited filing.

In the news

Seeking Alpha
SEC disclosures

Financials

FY 2025 · USD
Revenue12,453,000USD · FY 2025
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

Net income-7,492,000USD · FY 2025
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

Operating income231,000USD · FY 2025
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

Diluted EPS-0.12USD per share · FY 2025
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemQ3 2025Q3 2024Q2 2026Q2 2025Q2 2024Q1 2026Q1 2025Q1 2024FY 2025FY 2024FY 2023FY 2022
ASSETS
AssetsUSD20,756,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

As of 2025-09-30

27,343,000
Source

10-Q · 2024-11-19 · 0000950170-24-128621

As of 2024-09-30

16,370,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

As of 2026-06-30

23,344,000
Source

10-Q · 2025-08-14 · 0000950170-25-108770

As of 2025-06-30

25,939,000
Source

10-Q · 2024-09-10 · 0000950170-24-105016

As of 2024-06-30

18,696,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

As of 2026-03-31

22,478,000
Source

10-Q · 2025-05-15 · 0000950170-25-072520

As of 2025-03-31

29,543,000
Source

10-Q · 2024-09-10 · 0000950170-24-105004

As of 2024-03-31

21,436,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

As of 2025-12-31

23,602,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

As of 2024-12-31

35,179,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

As of 2023-12-31

48,225,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

As of 2022-12-31

Property, Plant and Equipment, NetUSD128,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

As of 2025-09-30

49,000
Source

10-Q · 2024-11-19 · 0000950170-24-128621

As of 2024-09-30

86,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

As of 2026-06-30

143,000
Source

10-Q · 2025-08-14 · 0000950170-25-108770

As of 2025-06-30

54,000
Source

10-Q · 2024-09-10 · 0000950170-24-105016

As of 2024-06-30

98,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

As of 2026-03-31

41,000
Source

10-Q · 2025-05-15 · 0000950170-25-072520

As of 2025-03-31

57,000
Source

10-Q · 2024-09-10 · 0000950170-24-105004

As of 2024-03-31

113,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

As of 2025-12-31

46,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

As of 2024-12-31

59,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

As of 2023-12-31

75,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

As of 2022-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD293,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

As of 2025-09-30

1,255,000
Source

10-Q · 2024-11-19 · 0000950170-24-128621

As of 2024-09-30

2,808,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

As of 2026-06-30

886,000
Source

10-Q · 2025-08-14 · 0000950170-25-108770

As of 2025-06-30

1,525,000
Source

10-Q · 2024-09-10 · 0000950170-24-105016

As of 2024-06-30

1,072,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

As of 2026-03-31

1,333,000
Source

10-Q · 2025-05-15 · 0000950170-25-072520

As of 2025-03-31

1,712,000
Source

10-Q · 2024-09-10 · 0000950170-24-105004

As of 2024-03-31

2,127,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

As of 2025-12-31

1,389,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

As of 2024-12-31

2,547,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

As of 2023-12-31

2,021,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

As of 2022-12-31

Accounts Receivable, after Allowance for Credit Loss, CurrentUSD2,619,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

As of 2025-09-30

4,938,000
Source

10-Q · 2024-11-19 · 0000950170-24-128621

As of 2024-09-30

709,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

As of 2026-06-30

2,071,000
Source

10-Q · 2025-08-14 · 0000950170-25-108770

As of 2025-06-30

4,598,000
Source

10-Q · 2024-09-10 · 0000950170-24-105016

As of 2024-06-30

2,048,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

As of 2026-03-31

2,061,000
Source

10-Q · 2025-05-15 · 0000950170-25-072520

As of 2025-03-31

2,990,000
Source

10-Q · 2024-09-10 · 0000950170-24-105004

As of 2024-03-31

2,804,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

As of 2025-12-31

2,623,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

As of 2024-12-31

5,524,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

As of 2023-12-31

375,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

As of 2022-12-31

Inventory, NetUSD1,213,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

As of 2025-09-30

1,610,000
Source

10-Q · 2024-11-19 · 0000950170-24-128621

As of 2024-09-30

1,589,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

As of 2026-06-30

1,313,000
Source

10-Q · 2025-08-14 · 0000950170-25-108770

As of 2025-06-30

1,628,000
Source

10-Q · 2024-09-10 · 0000950170-24-105016

As of 2024-06-30

1,909,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

As of 2026-03-31

1,437,000
Source

10-Q · 2025-05-15 · 0000950170-25-072520

As of 2025-03-31

1,527,000
Source

10-Q · 2024-09-10 · 0000950170-24-105004

As of 2024-03-31

1,555,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

As of 2025-12-31

1,635,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

As of 2024-12-31

1,711,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

As of 2023-12-31

2,379,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

As of 2022-12-31

Assets, CurrentUSD4,786,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

As of 2025-09-30

9,204,000
Source

10-Q · 2024-11-19 · 0000950170-24-128621

As of 2024-09-30

6,003,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

As of 2026-06-30

5,015,000
Source

10-Q · 2025-08-14 · 0000950170-25-108770

As of 2025-06-30

9,012,000
Source

10-Q · 2024-09-10 · 0000950170-24-105016

As of 2024-06-30

5,995,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

As of 2026-03-31

5,653,000
Source

10-Q · 2025-05-15 · 0000950170-25-072520

As of 2025-03-31

7,844,000
Source

10-Q · 2024-09-10 · 0000950170-24-105004

As of 2024-03-31

7,746,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

As of 2025-12-31

6,767,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

As of 2024-12-31

11,509,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

As of 2023-12-31

6,289,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

As of 2022-12-31

Prepaid Expense and Other Assets, CurrentUSD661,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

As of 2025-09-30

1,347,000
Source

10-Q · 2024-11-19 · 0000950170-24-128621

As of 2024-09-30

897,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

As of 2026-06-30

745,000
Source

10-Q · 2025-08-14 · 0000950170-25-108770

As of 2025-06-30

1,261,000
Source

10-Q · 2024-09-10 · 0000950170-24-105016

As of 2024-06-30

966,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

As of 2026-03-31

822,000
Source

10-Q · 2025-05-15 · 0000950170-25-072520

As of 2025-03-31

1,615,000
Source

10-Q · 2024-09-10 · 0000950170-24-105004

As of 2024-03-31

1,260,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

As of 2025-12-31

1,120,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

As of 2024-12-31

1,727,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

As of 2023-12-31

1,514,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

As of 2022-12-31

Operating Lease, Right-of-Use AssetUSD799,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

As of 2025-09-30

1,719,000
Source

10-Q · 2024-11-19 · 0000950170-24-128621

As of 2024-09-30

808,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

As of 2026-06-30

830,000
Source

10-Q · 2025-08-14 · 0000950170-25-108770

As of 2025-06-30

1,903,000
Source

10-Q · 2024-09-10 · 0000950170-24-105016

As of 2024-06-30

736,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

As of 2026-03-31

1,331,000
Source

10-Q · 2025-05-15 · 0000950170-25-072520

As of 2025-03-31

2,082,000
Source

10-Q · 2024-09-10 · 0000950170-24-105004

As of 2024-03-31

766,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

As of 2025-12-31

1,530,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

As of 2024-12-31

2,337,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

As of 2023-12-31

2,799,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

As of 2022-12-31

Other Assets, NoncurrentUSD167,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

As of 2025-09-30

312,000
Source

10-Q · 2024-11-19 · 0000950170-24-128621

As of 2024-09-30

202,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

As of 2026-06-30

168,000
Source

10-Q · 2025-08-14 · 0000950170-25-108770

As of 2025-06-30

308,000
Source

10-Q · 2024-09-10 · 0000950170-24-105016

As of 2024-06-30

203,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

As of 2026-03-31

222,000
Source

10-Q · 2025-05-15 · 0000950170-25-072520

As of 2025-03-31

310,000
Source

10-Q · 2024-09-10 · 0000950170-24-105004

As of 2024-03-31

207,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

As of 2025-12-31

222,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

As of 2024-12-31

296,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

As of 2023-12-31

263,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

As of 2022-12-31

LIABILITIES AND EQUITY
LiabilitiesUSD80,244,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

As of 2025-09-30

81,124,000
Source

10-Q · 2024-11-19 · 0000950170-24-128621

As of 2024-09-30

82,546,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

As of 2026-06-30

79,045,000
Source

10-Q · 2025-08-14 · 0000950170-25-108770

As of 2025-06-30

82,953,000
Source

10-Q · 2024-09-10 · 0000950170-24-105016

As of 2024-06-30

86,556,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

As of 2026-03-31

81,079,000
Source

10-Q · 2025-05-15 · 0000950170-25-072520

As of 2025-03-31

83,187,000
Source

10-Q · 2024-09-10 · 0000950170-24-105004

As of 2024-03-31

85,044,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

As of 2025-12-31

80,081,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

As of 2024-12-31

82,935,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

As of 2023-12-31

82,316,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

As of 2022-12-31

Stockholders’ equity:
Common Stock, Value, IssuedUSD64,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

As of 2025-09-30

64,000
Source

10-Q · 2024-11-19 · 0000950170-24-128621

As of 2024-09-30

70,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

As of 2026-06-30

64,000
Source

10-Q · 2025-08-14 · 0000950170-25-108770

As of 2025-06-30

64,000
Source

10-Q · 2024-09-10 · 0000950170-24-105016

As of 2024-06-30

70,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

As of 2026-03-31

64,000
Source

10-Q · 2025-05-15 · 0000950170-25-072520

As of 2025-03-31

62,000
Source

10-Q · 2024-09-10 · 0000950170-24-105004

As of 2024-03-31

70,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

As of 2025-12-31

64,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

As of 2024-12-31

62,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

As of 2023-12-31

50,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

As of 2022-12-31

Retained Earnings (Accumulated Deficit)USD-268,116,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

As of 2025-09-30

-260,827,000
Source

10-Q · 2024-11-19 · 0000950170-24-128621

As of 2024-09-30

-272,063,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

As of 2026-06-30

-266,040,000
Source

10-Q · 2025-08-14 · 0000950170-25-108770

As of 2025-06-30

-262,654,000
Source

10-Q · 2024-09-10 · 0000950170-24-105016

As of 2024-06-30

-273,402,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

As of 2026-03-31

-264,905,000
Source

10-Q · 2025-05-15 · 0000950170-25-072520

As of 2025-03-31

-260,470,000
Source

10-Q · 2024-09-10 · 0000950170-24-105004

As of 2024-03-31

-270,067,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

As of 2025-12-31

-262,575,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

As of 2024-12-31

-256,122,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

As of 2023-12-31

-252,337,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

As of 2022-12-31

Accumulated Other Comprehensive Income (Loss), Net of TaxUSD-481,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

As of 2025-09-30

-2,016,000
Source

10-Q · 2024-11-19 · 0000950170-24-128621

As of 2024-09-30

-3,302,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

As of 2026-06-30

1,239,000
Source

10-Q · 2025-08-14 · 0000950170-25-108770

As of 2025-06-30

-3,394,000
Source

10-Q · 2024-09-10 · 0000950170-24-105016

As of 2024-06-30

-3,647,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

As of 2026-03-31

-2,797,000
Source

10-Q · 2025-05-15 · 0000950170-25-072520

As of 2025-03-31

-1,870,000
Source

10-Q · 2024-09-10 · 0000950170-24-105004

As of 2024-03-31

-2,729,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

As of 2025-12-31

-2,995,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

As of 2024-12-31

-160,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

As of 2023-12-31

-2,619,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

As of 2022-12-31

Stockholders' Equity Attributable to ParentUSD-59,488,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

As of 2025-09-30

-53,781,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

As of 2024-09-30

-66,176,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

As of 2026-06-30

-55,701,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

As of 2025-06-30

-57,014,000
Source

10-Q · 2025-08-14 · 0000950170-25-108770

As of 2024-06-30

-67,860,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

As of 2026-03-31

-58,601,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

As of 2025-03-31

-53,644,000
Source

10-Q · 2025-05-15 · 0000950170-25-072520

As of 2024-03-31

-63,608,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

As of 2025-12-31

-56,479,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

As of 2024-12-31

-47,756,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

As of 2023-12-31

-34,091,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

As of 2022-12-31

Additional Paid in Capital, Common StockUSD225,914,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

As of 2025-09-30

225,867,000
Source

10-Q · 2024-11-19 · 0000950170-24-128621

As of 2024-09-30

225,988,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

As of 2026-06-30

225,905,000
Source

10-Q · 2025-08-14 · 0000950170-25-108770

As of 2025-06-30

225,839,000
Source

10-Q · 2024-09-10 · 0000950170-24-105016

As of 2024-06-30

225,988,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

As of 2026-03-31

225,906,000
Source

10-Q · 2025-05-15 · 0000950170-25-072520

As of 2025-03-31

225,503,000
Source

10-Q · 2024-09-10 · 0000950170-24-105004

As of 2024-03-31

225,987,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

As of 2025-12-31

225,896,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

As of 2024-12-31

225,333,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

As of 2023-12-31

220,815,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

As of 2022-12-31

Liabilities and EquityUSD20,756,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

As of 2025-09-30

27,343,000
Source

10-Q · 2024-11-19 · 0000950170-24-128621

As of 2024-09-30

16,370,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

As of 2026-06-30

23,344,000
Source

10-Q · 2025-08-14 · 0000950170-25-108770

As of 2025-06-30

25,939,000
Source

10-Q · 2024-09-10 · 0000950170-24-105016

As of 2024-06-30

18,696,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

As of 2026-03-31

22,478,000
Source

10-Q · 2025-05-15 · 0000950170-25-072520

As of 2025-03-31

29,543,000
Source

10-Q · 2024-09-10 · 0000950170-24-105004

As of 2024-03-31

21,436,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

As of 2025-12-31

23,602,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

As of 2024-12-31

35,179,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

As of 2023-12-31

48,225,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

As of 2022-12-31

Current liabilities:
Liabilities, CurrentUSD64,169,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

As of 2025-09-30

64,131,000
Source

10-Q · 2024-11-19 · 0000950170-24-128621

As of 2024-09-30

66,116,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

As of 2026-06-30

62,076,000
Source

10-Q · 2025-08-14 · 0000950170-25-108770

As of 2025-06-30

64,025,000
Source

10-Q · 2024-09-10 · 0000950170-24-105016

As of 2024-06-30

70,537,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

As of 2026-03-31

64,915,000
Source

10-Q · 2025-05-15 · 0000950170-25-072520

As of 2025-03-31

62,428,000
Source

10-Q · 2024-09-10 · 0000950170-24-105004

As of 2024-03-31

69,072,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

As of 2025-12-31

63,555,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

As of 2024-12-31

61,507,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

As of 2023-12-31

54,323,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

As of 2022-12-31

Operating Lease, Liability, CurrentUSD348,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

As of 2025-09-30

2,329,000
Source

10-Q · 2024-11-19 · 0000950170-24-128621

As of 2024-09-30

390,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

As of 2026-06-30

348,000
Source

10-Q · 2025-08-14 · 0000950170-25-108770

As of 2025-06-30

903,000
Source

10-Q · 2024-09-10 · 0000950170-24-105016

As of 2024-06-30

349,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

As of 2026-03-31

2,676,000
Source

10-Q · 2025-05-15 · 0000950170-25-072520

As of 2025-03-31

869,000
Source

10-Q · 2024-09-10 · 0000950170-24-105004

As of 2024-03-31

348,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

As of 2025-12-31

2,423,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

As of 2024-12-31

865,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

As of 2023-12-31

703,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

As of 2022-12-31

Accounts Payable, CurrentUSD5,362,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

As of 2025-09-30

6,489,000
Source

10-Q · 2024-11-19 · 0000950170-24-128621

As of 2024-09-30

4,348,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

As of 2026-06-30

4,562,000
Source

10-Q · 2025-08-14 · 0000950170-25-108770

As of 2025-06-30

7,214,000
Source

10-Q · 2024-09-10 · 0000950170-24-105016

As of 2024-06-30

5,810,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

As of 2026-03-31

4,807,000
Source

10-Q · 2025-05-15 · 0000950170-25-072520

As of 2025-03-31

6,565,000
Source

10-Q · 2024-09-10 · 0000950170-24-105004

As of 2024-03-31

5,979,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

As of 2025-12-31

5,175,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

As of 2024-12-31

5,887,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

As of 2023-12-31

3,785,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

As of 2022-12-31

Operating Lease, Liability, NoncurrentUSD1,498,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

As of 2025-09-30

1,076,000
Source

10-Q · 2024-11-19 · 0000950170-24-128621

As of 2024-09-30

1,299,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

As of 2026-06-30

1,584,000
Source

10-Q · 2025-08-14 · 0000950170-25-108770

As of 2025-06-30

1,322,000
Source

10-Q · 2024-09-10 · 0000950170-24-105016

As of 2024-06-30

1,324,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

As of 2026-03-31

544,000
Source

10-Q · 2025-05-15 · 0000950170-25-072520

As of 2025-03-31

1,561,000
Source

10-Q · 2024-09-10 · 0000950170-24-105004

As of 2024-03-31

1,409,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

As of 2025-12-31

815,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

As of 2024-12-31

1,839,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

As of 2023-12-31

2,553,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

As of 2022-12-31

Other Liabilities, NoncurrentUSD12,313,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

As of 2025-09-30

13,676,000
Source

10-Q · 2024-11-19 · 0000950170-24-128621

As of 2024-09-30

12,884,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

As of 2026-06-30

13,128,000
Source

10-Q · 2025-08-14 · 0000950170-25-108770

As of 2025-06-30

15,370,000
Source

10-Q · 2024-09-10 · 0000950170-24-105016

As of 2024-06-30

12,418,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

As of 2026-03-31

13,369,000
Source

10-Q · 2025-05-15 · 0000950170-25-072520

As of 2025-03-31

16,967,000
Source

10-Q · 2024-09-10 · 0000950170-24-105004

As of 2024-03-31

12,292,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

As of 2025-12-31

13,465,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

As of 2024-12-31

17,363,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

As of 2023-12-31

21,714,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

As of 2022-12-31

Additional Financial Items
Accrued Liabilities, CurrentUSD9,562,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

As of 2025-09-30

7,864,000
Source

10-Q · 2024-11-19 · 0000950170-24-128621

As of 2024-09-30

9,944,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

As of 2026-06-30

9,032,000
Source

10-Q · 2025-08-14 · 0000950170-25-108770

As of 2025-06-30

8,163,000
Source

10-Q · 2024-09-10 · 0000950170-24-105016

As of 2024-06-30

10,238,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

As of 2026-03-31

8,740,000
Source

10-Q · 2025-05-15 · 0000950170-25-072520

As of 2025-03-31

8,519,000
Source

10-Q · 2024-09-10 · 0000950170-24-105004

As of 2024-03-31

9,321,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

As of 2025-12-31

7,732,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

As of 2024-12-31

8,174,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

As of 2023-12-31

7,239,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

As of 2022-12-31

Long-term DebtUSD29,069,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

As of 2025-09-30

29,298,000
Source

10-Q · 2024-11-19 · 0000950170-24-128621

As of 2024-09-30

24,986,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

As of 2026-06-30

29,732,000
Source

10-Q · 2025-08-14 · 0000950170-25-108770

As of 2025-06-30

29,371,000
Source

10-Q · 2024-09-10 · 0000950170-24-105016

As of 2024-06-30

26,558,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

As of 2026-03-31

29,006,000
Source

10-Q · 2025-05-15 · 0000950170-25-072520

As of 2025-03-31

29,436,000
Source

10-Q · 2024-09-10 · 0000950170-24-105004

As of 2024-03-31

27,128,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

As of 2025-12-31

28,965,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

As of 2024-12-31

30,563,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

As of 2023-12-31

30,418,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

As of 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD——————-3,335,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

-2,330,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

-7,492,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

-6,453,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

-3,733,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

-10,625,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, Depletion and AmortizationUSD——————15,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

5,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

39,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

22,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

32,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

53,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Share-based Payment Arrangement, Noncash ExpenseUSD——————1,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

10,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

25,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

256,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

1,262,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

16,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Changes in operating assets and liabilities:
Increase (Decrease) in Accounts ReceivableUSD——————-756,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

-562,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

182,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

-2,900,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

5,149,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

-607,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Increase (Decrease) in InventoriesUSD——————351,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

-199,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

21,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

-7,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

-650,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

-434,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Net Cash Provided by (Used in) Operating ActivitiesUSD——————-344,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

279,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

-11,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

-2,286,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

-1,503,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

-5,073,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD——————0
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

0
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

2,171,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

2,500,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

-432,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

-2,387,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Payments to Acquire Property, Plant, and EquipmentUSD————————1,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

12,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

17,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

26,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD——————-702,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

-345,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

-1,425,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

-1,353,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

2,477,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

7,233,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD——————-1,055,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

-56,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

738,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

-1,158,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

526,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

-258,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD——————808,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

415,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

2,528,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

2,246,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

2,453,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

1,335,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Income Taxes Paid, NetUSD——————-1,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

0
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

23,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

48,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

83,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

—
Additional Financial Items
DepreciationUSD——15,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2025-07-01 to 2025-09-30

5,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2024-07-01 to 2024-09-30

14,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2026-04-01 to 2026-06-30

4,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2025-04-01 to 2025-06-30

15,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

5,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

39,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

22,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

32,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

39,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Foreign Currency Transaction Gain (Loss), before TaxUSD——-32,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2025-07-01 to 2025-09-30

-117,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2024-07-01 to 2024-09-30

9,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2026-04-01 to 2026-06-30

134,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2025-04-01 to 2025-06-30

-130,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

-152,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

26,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

-148,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

-1,767,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

-2,662,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Foreign Currency Transaction Gain (Loss), UnrealizedUSD——————22,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

-141,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

38,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

245,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

-1,911,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

-2,773,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Gain (Loss) on Disposition of Property Plant EquipmentUSD——————————-1,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

-2,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Gain (Loss) on Termination of LeaseUSD———————————-31,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Gain (Loss) on Extinguishment of DebtUSD——-296,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2025-07-01 to 2025-09-30

0
Source

10-Q · 2024-11-19 · 0000950170-24-128621

2024-07-01 to 2024-09-30

0
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2026-04-01 to 2026-06-30

-212,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2025-04-01 to 2025-06-30

-76,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

-164,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

-1,363,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

—-821,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

-501,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

General and Administrative ExpenseUSD——1,731,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2025-07-01 to 2025-09-30

2,799,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2024-07-01 to 2024-09-30

1,574,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2026-04-01 to 2026-06-30

2,307,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2025-04-01 to 2025-06-30

1,850,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

2,339,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

8,179,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

10,687,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

14,891,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

13,170,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Income (Loss) from Equity Method InvestmentsUSD———0
Source

10-Q · 2024-11-19 · 0000950170-24-128621

2024-07-01 to 2024-09-30

——————-1,713,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

-1,913,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD——579,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2025-07-01 to 2025-09-30

-1,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2024-07-01 to 2024-09-30

-1,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2026-04-01 to 2026-06-30

-590,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2025-04-01 to 2025-06-30

4,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

4,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

9,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

29,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

-59,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

60,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD——-2,076,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2025-07-01 to 2025-09-30

1,827,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2024-07-01 to 2024-09-30

1,339,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2026-04-01 to 2026-06-30

-1,135,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2025-04-01 to 2025-06-30

-3,335,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

-2,330,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

-7,492,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

-6,453,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

-3,733,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

-10,625,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Operating ExpensesUSD——2,436,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2025-07-01 to 2025-09-30

4,263,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2024-07-01 to 2024-09-30

2,183,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2026-04-01 to 2026-06-30

3,037,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2025-04-01 to 2025-06-30

2,637,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

3,161,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

11,365,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

17,346,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

24,715,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

22,388,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Operating Lease, ExpenseUSD——90,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2025-07-01 to 2025-09-30

263,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2024-07-01 to 2024-09-30

103,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2026-04-01 to 2026-06-30

97,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2025-04-01 to 2025-06-30

90,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

249,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

500,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

1,100,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

1,200,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

1,100,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Debt Securities, Realized Gain (Loss)————————————
Equity Securities, FV-NI, Unrealized Gain (Loss)—————
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2026-04-01 to 2026-06-30

—
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2025-04-01 to 2025-06-30

——————
Net Income (Loss) Available to Common Stockholders, Basic—————
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2026-04-01 to 2026-06-30

—
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2025-04-01 to 2025-06-30

——————

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Total RevenueUSD——3,378,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2025-07-01 to 2025-09-30

5,478,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2024-07-01 to 2024-09-30

6,318,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2026-04-01 to 2026-06-30

2,817,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2025-04-01 to 2025-06-30

1,982,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

2,406,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

12,453,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

16,653,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

29,597,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

18,390,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Cost of Goods and Services Sold———
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2025-07-01 to 2025-09-30

—
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2024-07-01 to 2024-09-30

—
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2026-04-01 to 2026-06-30

—
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2025-04-01 to 2025-06-30

—
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

—
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

—
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

—
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

—
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

—
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Operating Income (Loss)USD——695,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2025-07-01 to 2025-09-30

821,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2024-07-01 to 2024-09-30

3,791,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2026-04-01 to 2026-06-30

-370,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2025-04-01 to 2025-06-30

-823,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

-980,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

231,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

-1,894,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

3,540,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

-6,586,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD——-1,497,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2025-07-01 to 2025-09-30

1,826,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2024-07-01 to 2024-09-30

1,338,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2026-04-01 to 2026-06-30

-1,725,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2025-04-01 to 2025-06-30

-3,331,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

-2,326,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

-7,483,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

-6,424,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

-3,792,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

-10,565,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD——579,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2025-07-01 to 2025-09-30

-1,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2024-07-01 to 2024-09-30

-1,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2026-04-01 to 2026-06-30

-590,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2025-04-01 to 2025-06-30

4,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

4,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

9,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

29,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

-59,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

60,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD——-2,076,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2025-07-01 to 2025-09-30

1,827,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2024-07-01 to 2024-09-30

1,339,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2026-04-01 to 2026-06-30

-1,135,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2025-04-01 to 2025-06-30

-3,335,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

-2,330,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

-7,492,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

-6,453,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

-3,733,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

-10,625,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Earnings Per Share, BasicUSD per share——-0.03
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2025-07-01 to 2025-09-30

0.03
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2024-07-01 to 2024-09-30

0.02
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2026-04-01 to 2026-06-30

-0.02
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2025-04-01 to 2025-06-30

-0.05
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

-0.04
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

-0.12
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

-0.1
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

-0.07
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

-0.21
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Earnings Per Share, DilutedUSD per share——-0.03
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2025-07-01 to 2025-09-30

0.03
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2024-07-01 to 2024-09-30

0.02
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2026-04-01 to 2026-06-30

-0.02
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2025-04-01 to 2025-06-30

-0.05
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

-0.04
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

-0.12
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

-0.1
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

-0.07
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

-0.21
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Basicshares——63,865,571
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2025-07-01 to 2025-09-30

63,865,571
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2024-07-01 to 2024-09-30

70,188,263
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2026-04-01 to 2026-06-30

63,865,571
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2025-04-01 to 2025-06-30

70,188,263
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

63,865,571
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

64,038,795
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

63,234,789
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

53,105,388
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

49,439,867
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Dilutedshares——63,865,571
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2025-07-01 to 2025-09-30

63,865,571
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2024-07-01 to 2024-09-30

120,537,248
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2026-04-01 to 2026-06-30

63,865,571
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2025-04-01 to 2025-06-30

70,188,263
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

63,865,571
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

64,038,795
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

63,234,789
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

53,105,388
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

49,439,867
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Additional Financial Items
Current Income Tax Expense (Benefit)USD————————9,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

———
Foreign Currency Transaction Gain (Loss), before TaxUSD——-32,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2025-07-01 to 2025-09-30

-117,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2024-07-01 to 2024-09-30

9,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2026-04-01 to 2026-06-30

134,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2025-04-01 to 2025-06-30

-130,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

-152,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

26,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

-148,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

-1,767,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

-2,662,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

General and Administrative ExpenseUSD——1,731,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2025-07-01 to 2025-09-30

2,799,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2024-07-01 to 2024-09-30

1,574,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2026-04-01 to 2026-06-30

2,307,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2025-04-01 to 2025-06-30

1,850,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

2,339,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

8,179,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

10,687,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

14,891,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

13,170,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Gross ProfitUSD——3,131,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2025-07-01 to 2025-09-30

5,084,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2024-07-01 to 2024-09-30

5,974,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2026-04-01 to 2026-06-30

2,667,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2025-04-01 to 2025-06-30

1,814,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

2,181,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

11,596,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

15,452,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

28,255,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

15,802,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD————————-7,473,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

———
Income (Loss) from Equity Method InvestmentsUSD———0
Source

10-Q · 2024-11-19 · 0000950170-24-128621

2024-07-01 to 2024-09-30

——————-1,713,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

-1,913,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Interest and Other IncomeUSD——65,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2025-07-01 to 2025-09-30

145,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2024-07-01 to 2024-09-30

49,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2026-04-01 to 2026-06-30

67,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2025-04-01 to 2025-06-30

61,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

73,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

270,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

274,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

681,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

680,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Interest ExpenseUSD——1,931,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2025-07-01 to 2025-09-30

1,338,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2024-07-01 to 2024-09-30

1,596,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2026-04-01 to 2026-06-30

1,678,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2025-04-01 to 2025-06-30

2,126,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

1,256,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

7,134,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

5,492,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

7,383,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

5,013,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Operating ExpensesUSD——2,436,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2025-07-01 to 2025-09-30

4,263,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2024-07-01 to 2024-09-30

2,183,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2026-04-01 to 2026-06-30

3,037,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2025-04-01 to 2025-06-30

2,637,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

3,161,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

11,365,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

17,346,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

24,715,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

22,388,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Operating Lease, ExpenseUSD——90,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2025-07-01 to 2025-09-30

263,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2024-07-01 to 2024-09-30

103,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2026-04-01 to 2026-06-30

97,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2025-04-01 to 2025-06-30

90,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

249,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

500,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

1,100,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

1,200,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

1,100,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Research and Development ExpenseUSD——50,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2025-07-01 to 2025-09-30

146,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2024-07-01 to 2024-09-30

116,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2026-04-01 to 2026-06-30

56,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2025-04-01 to 2025-06-30

40,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

176,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

313,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

657,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

1,189,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

1,725,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Selling and Marketing ExpenseUSD——655,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2025-07-01 to 2025-09-30

1,318,000
Source

10-Q · 2025-11-14 · 0001193125-25-282675

2024-07-01 to 2024-09-30

493,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2026-04-01 to 2026-06-30

674,000
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2025-04-01 to 2025-06-30

747,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2026-01-01 to 2026-03-31

646,000
Source

10-Q · 2026-05-15 · 0001193125-26-226362

2025-01-01 to 2025-03-31

2,873,000
Source

10-K · 2026-03-31 · 0001193125-26-132925

2025-01-01 to 2025-12-31

6,002,000
Source

10-K · 2025-04-14 · 0000950170-25-053744

2024-01-01 to 2024-12-31

8,635,000
Source

10-K · 2024-07-03 · 0000950170-24-080918

2023-01-01 to 2023-12-31

7,493,000
Source

10-K · 2023-03-31 · 0000950170-23-011328

2022-01-01 to 2022-12-31

Debt Securities, Realized Gain (Loss)————————————
Net Income (Loss) Available to Common Stockholders, Basic—————
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2026-04-01 to 2026-06-30

—
Source

10-Q · 2026-08-14 · 0001193125-26-351833

2025-04-01 to 2025-06-30

——————

Lines labelled “Derived” are calculated from reported figures.

Filing attachments

ea030209901ex99-1.htm · 8-K · 2026-08-14

EX-99.1 2 ea030209901ex99-1.htm PRESS RELEASE DATED AUGUST 14, 2026 Exhibit 99.1 Emmaus Life Sciences Reports Quarterly Financial Results Torrance CA, August 14, 2026 - Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its financial condition and results of operations as of and for the three and six months ended June 30, 2026. Highlights “Under our previously announced License and E…

8-K · 2026-08-14 · 0001213900-26-089912

Read attachment ↗
ea029089601ex99-1.htm · 8-K · 2026-05-15

EX-99.1 2 ea029089601ex99-1.htm PRESS RELEASE DATED MAY 15, 2026 Exhibit 99.1 Emmaus Life Sciences Reports Quarterly Financial Results Torrance CA, May 15, 2026 - Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its financial condition and results of operations as of and for the three months ended March 31, 2026. Highlights “We realized an 18% decline in net revenues for three mont…

8-K · 2026-05-15 · 0001213900-26-057828

Read attachment ↗
ea028389901ex99-1.htm · 8-K · 2026-03-31

EX-99.1 2 ea028389901ex99-1.htm PRESS RELEASE DATED MARCH 30, 2026 Exhibit 99.1 Emmaus Life Sciences Reports Annual Financial Results Torrance CA, March 30, 2026 - Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its financial condition and results of operations as of and for the year ended December 31, 2025. Highlights “We experienced a 25% decline in net revenues in 2025 as compa…

8-K · 2026-03-31 · 0001213900-26-036886

Read attachment ↗
ea027134801ex99-1_emmaus.htm · 8-K · 2025-12-31

EX-99.1 2 ea027134801ex99-1_emmaus.htm PRESS RELEASE ISSUED DECEMBER 30, 2025 Exhibit 99.1 Emmaus Life Sciences Announces Strategic Transaction Enters into North American License and Exclusive Distribution Agreement Torrance CA, December 30, 2025 - Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today announced that it has entered into a License and Exclusive Distribution Agreement with NeoImmuneTec…

8-K · 2025-12-31 · 0001213900-25-126728

Read attachment ↗
ea027028901ex4-1_emmaus.htm · 8-K · 2025-12-22

EX-4.1 2 ea027028901ex4-1_emmaus.htm CONVERTIBLE PROMISSORY NOTE ISSUED DECEMBER 17. 2025 Exhibit 4.1 NEITHER THIS CONVERTIBLE PROMISSORY NOTE NOR THE SECURITIES ISSUABLE HEREUNDER HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION …

8-K · 2025-12-22 · 0001213900-25-124513

Read attachment ↗
ea026551601ex99-1_emmaus.htm · 8-K · 2025-11-14

EX-99.1 2 ea026551601ex99-1_emmaus.htm NOVEMBER 14, 2025 PRESS RELEASE Exhibit 99.1 Emmaus Life Sciences Reports Quarterly Financial Results Torrance CA, November 14, 2025 - Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its financial condition and results of operations as of and for the three and nine months ended September 30, 2025. Highlights “We experienced a 38% decline in n…

8-K · 2025-11-14 · 0001213900-25-110878

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.